Stay alert to the latest and greatest on stem cells. Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.
Bonus: In major news yesterday, Merck KGaA announced it had completed its acquisition of Sigma-Aldrich Corporation for $140 per share, a deal valued at $17.0 billion. Merck will now offer 300,000+ products, making it the new behemoth within the $130 billion life science industry.
Want to get this fun weekly update? Join below and we’ll keep you in the loop, starting next week.
Need advanced market analysis? View our global strategic reports for the stem cell and cord blood industry.